Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial
Judith A. Aberg, Craig A. Sponseller, Douglas J. Ward, Vladimir A. Kryzhanovski, Stuart E. Campbell, Melanie A. Thompson
Research output: Contribution to journal › Article › peer-review
66Scopus
citations
Fingerprint
Dive into the research topics of 'Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial'. Together they form a unique fingerprint.